Measures of response in clinical trials of systemic sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and outcome measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS)

Journal of Rheumatology

Volumn 36, Issue 10, 2009, Pages 2356-2361

  Khanna, Dinesh ^a   Distler, Oliver ^b   Avouac, Jerome ^c   Behrens, Frank ^d   Clements, Philip J ^a   Denton, Christopher ^e   Foeldvari, Ivan ^f   Giannini, Edward ^h   Huscher, Doerte ⁱ   Kowal Bielecka, Otylia ^j   Lovell, Daniel ^h   Matucci Cerinic, Marco ^k   Mayes, Maureen ^l   Merkel, Peter A ^m   Nash, Peter ⁿ   Opitz, Christian F ^o   Pittrow, David ^p   Rubin, Lewis ^q   Seibold, James R ^r   Steen, Virginia ^s   Strand, C Vibeke ^t   Tugwell, Peter S ^u   Varga, John ^v   Zink, Angela ^w   Furst, Daniel E ^g   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d GOETHE UNIVERSITY   (Germany)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f General Hospital Eilbek   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ German Arthritis Research Center   (Germany)

^j MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^k UNIVERSITY OF FLORENCE   (Italy)

^l UNIVERSITY OF TEXAS   (United States)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF QUEENSLAND   (Australia)

^o DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^p DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^q UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^r UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^s GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^t STANFORD UNIVERSITY   (United States)

^u Institute of Population Health   (Canada)

^v NORTHWESTERN UNIVERSITY   (United States)

^w German Rheumatism Research Centre   (Germany)

more..

Author keywords

Clinical trials; Criss; Eposs; Omeract; Outcomes; Scleroderma

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL TRIAL; CONFERENCE PAPER; DELPHI STUDY; DYSPNEA; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART CATHETERIZATION; HEART FUNCTION; HUMAN; LUNG ARTERY PRESSURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SCLERODERMA; SHORT FORM 36; SURVIVAL; SYSTEMIC SCLEROSIS; ULCER;

CLINICAL TRIALS AS TOPIC; CONSENSUS; DELPHI TECHNIQUE; DISABILITY EVALUATION; HUMANS; HYPERTENSION, PULMONARY; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70450202550     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090372     Document Type: Conference Paper

References (19)

1. Furst DE, Khanna D, Mattuci-Cerinic M, Silman AJ, Merkel PA, Foeldvari I. Scleroderma - developing measures of response. J Rheumatol 2005;32:2477-2480.
2. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-944.
3. Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Furst D, et al. Current status of outcome measure development for clinical trials in systemic sclerosis. J Rheumatol 2003;30:1630-1647.
4. Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA, et al. Development of the Scleroderma Gastrointestinal Tract 1.0 (SSc-GIT 1.0) quality of life instrument - preliminary report [abstract]. Arthritis Rheum 2006;54 Suppl:S479.
5. Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, et al. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum 2006;55:603-609. (Pubitemid 44289881)
6. White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum 1995;38:351-360.
7. Charles C, Clements P, Furst DE. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet 2006;367:1683-1691. (Pubitemid 43728250)
8. Varga J. Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-1713. (Pubitemid 34774500)
9. Varga J. Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts? Curr Rheumatol Rep 2004;6:164-170.
10. Clements P, Lachenbruch P, Siebold J, White B, Wiener S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-1285.
11. Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000;43:2445-2454. (Pubitemid 30829268)
12. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-735.
13. Singh JA, Solomon DH, Dougados M, Felson D, Hawker G, Katz P, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-352. (Pubitemid 43887018)
14. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-1209.
15. Distler O, Behrens F, Huscher D, Foeldvari I, Zink A, Nash P, et al. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Rheumatology 2006;45:1455-1457. (Pubitemid 44817048)
16. Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, et al. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis Rheum 2008;15:867-875. (Pubitemid 351847571)
17. Allanore Y, Meune C, Avouac J, Wipff J, Mouthon L, Guillevin L, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography in routine care: a controlled study of 100 consecutive patients [abstract]. Ann Rheum Dis 2008;67 Suppl II:361 [FRI0241].
18. Avouac J, Wipff M, Kahan A, Allanore Y. Effects of new oral treatments on exercise capacity in connective tissue disease related pulmonary arterial hypertension: a meta-analysis of randomized controlled trials [abstract]. Ann Rheum Dis 2008;67 Suppl II:361 [FRI0242].
19. Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, et al. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 2008;67:703-709 (Pubitemid 351571937)